Cybin’s Clinical Trial Indicates Promising Results for Psychedelic Mental Health Treatment
A Canadian biopharmaceutical firm, Cybin, has shared promising results from ...
U.S. States Navigate Psychedelics Reforms Amidst Legalization Efforts
As the United States continues to explore the boundaries of ...
Colorado Cannabis Business Park Entangled in Legal Battle Over Unpaid Electricity Bills
NEW YORK — A legal tussle over a six-figure electricity ...
Florida Medical Cannabis Company Challenges State Over Licensing Fee Spike
NEW YORK — Sanctuary Cannabis, a player in Florida's medical ...
Ohio’s Cannabis Industry Eyes Adult-Use Legalization with Hope and Vigilance
LOS ANGELES- Ohio’s medical cannabis industry is looking toward the ...
Ohio Decides On Adult-Use Legalization of Cannabis
CLEVELAND, Ohio – In Ohio, a momentous decision looms large ...
Organigram Stock Rallies On $124.6 Million Investment from British American Tobacco Subsidiary
TORONTO- In a significant financial development, Organigram Holdings Inc. (NASDAQ: ...
Alabama Medical Cannabis Commission Sets December Goal for Licensing Amid Legal Challenges
Alabama — After navigating through a series of legal hurdles ...
Kansas City Cannabis Workers Vote to Unionize, Joining Teamsters Local 955
LOS ANGELES— Employees at Home State Dispensary in Kansas City ...
MindMed Projects Operational Continuity into 2026 Amid Advancements in LSD-Based Anxiety Treatment
NEW YORK — Mind Medicine Inc. (MindMed), a biopharmaceutical company leading ...
